Key Influencer in the Endocrine Peptide Test Market 2025: Impact of Diabetes Prevalence on Endocrine Peptide Test Market Growth Driver

What Is the Forecasted Market Size and Growth Rate for the Endocrine Peptide Test Market?
The market size for endocrine peptide tests has significantly expanded in the recent past. The growth is slated to rise from $9.11 billion in 2024 to a significant $9.97 billion in 2025. This translates to a compound annual growth rate (CAGR) of 9.5%. The expansion during the historic phase is linked to factors like increased government expenditures, a surge in cases of diabetes, a fall in immunity levels among global population, an augmented risk of chronic disease contraction, and an upswing in government initiatives.

In the coming years, the market size for endocrine peptide tests is anticipated to experience robust growth, eventually reaching $14.22 billion in 2029, at a compound annual growth rate (CAGR) of 9.3%. This expected growth during the forecast period is due to factors such as growing demand for endocrine peptide tests

What Factors Are Fueling Growth in the Endocrine Peptide Test Market?
The growth of the endocrine peptide test market is anticipated to be fueled by the escalating prevalence of diabetes. Diabetes is a cluster of conditions that lead to elevated blood sugar (glucose) levels. The rise in diabetes cases can be attributed to a number of factors including unhealthy eating habits, inactive lifestyles, genetic vulnerability, and an aging demographic. The endocrine peptide test, incorporating tests such as hemoglobin A1c, fasting plasma glucose, and C-peptide, plays a crucial role in diagnosing diabetes, tracking glucose levels and evaluating insulin production and responsiveness. For example, data from the National Health Service (NHS), a government agency in the UK, revealed a significant increase in the number of individuals under 40 diagnosed with diabetes, escalating from 173,166 in 2022 to 216,440 in 2023. This rapid surge indicates a worrying trend of growing diabetes prevalence amongst younger demographics. As such, the surge in diabetes cases is propelling the endocrine peptide test market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16675&type=smp

Which Businesses Are at the Forefront of Endocrine Peptide Test Market Development?
Major companies operating in the endocrine peptide test market are Siemens AG, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMérieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Sciex, Bio-Techne Corporation, Invitae Corporation, ARUP Laboratories, Genova Diagnostics, Boston Heart Diagnostics Corporation, Immunodiagnostic Systems Ltd., Mayo Clinic Laboratories

What Are the Latest Innovations in the Endocrine Peptide Test Market?
Leading entities in the endocrine peptide test market are devising immunoassay testing systems to enhance the precision, sensitivity, and pace of endocrine peptide testing. These systems employ antibodies to identify and quantify specific peptides in blood or urine specimens, offering crucial insights to healthcare providers about hormone levels and endocrine function. For example, in July 2023, German healthcare services firm, Siemens Healthineers, introduced the Atellica CI Analyzer, a small-scale system for immunoassay and clinical chemistry testing, inclusive of endocrine peptide assays. The analyzer also incorporates a reproductive endocrinology menu, with anti-Mullerian hormone (AMH) for assessing ovarian reserve, and sFlt-1 and PlGF (placental growth factor) for assisting in the prognosis of preeclampsia. Crafted to provide reliable results rapidly and consistently, Atellica CI Analyzer has a capacity of running up to 1000 tests per hour. It enhances workflow efficiency and adaptability, assisting labs in addressing changing testing requirements.

How Is the Endocrine Peptide Test Market Segmented?
The endocrine peptide test market covered in this report is segmented -

1) By Test-Type: Dehydroepiandrosterone Sulphate, Progesterone, Luteinizing Hormone, Thyroid Prolactin, Oestradiol, Human Chorionic Gonadotropin, Thyroid-Stimulating Hormone, Other Test-Types
2) By Technology: Mass Spectroscopy, Immunoassay, Chromatography, Nucleic Acid Based, Other Technologies
3) By End-User: Clinics, Healthcare Centers, Hospitals, Commercial Laboratories

Subsegments:
1) By Dehydroepiandrosterone Sulphate (DHEA-S): Immunoassay Tests, Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)
2) By Progesterone: Immunoassay Tests, Chemiluminescence Assays, ELISA Tests
3) By Luteinizing Hormone (LH): Immunoassay Tests, Enzyme Immunoassay (EIA), Radioimmunoassay (RIA)
4) By Thyroid Prolactin: Immunoassay Tests, Chemiluminescence Assays, Radioimmunoassay (RIA)
5) By Oestradiol: Immunoassay Tests, Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)
6) By Human Chorionic Gonadotropin (hCG): Immunoassay Tests, Chemiluminescence Assays, Enzyme Immunoassay (EIA)
7) By Thyroid-Stimulating Hormone (TSH): Immunoassay Tests, Radioimmunoassay (RIA), Enzyme-Linked Immunosorbent Assay (ELISA)
8) Other Test-Types: Cortisol, Insulin, Growth Hormone (GH), Parathyroid Hormone (PTH)

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/endocrine-peptide-test-global-market-report

Where Is the Endocrine Peptide Test Market Growth Most Prominent?
North America was the largest region in the endocrine peptide test market in 2024. The regions covered in the endocrine peptide test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Endocrine Peptide Test Global Market Report?

- Market Size Analysis: Analyze the Endocrine Peptide Test Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Endocrine Peptide Test Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Endocrine Peptide Test Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Endocrine Peptide Test Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16675

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.